About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

High Intra-tumour Heterogeneity Doubles Risk of Death from Breast Cancer

by Anjali Aryamvally on January 20, 2018 at 1:02 PM
Font : A-A+

High Intra-tumour Heterogeneity Doubles Risk of Death from Breast Cancer

The risk of death from breast cancer is twice as high for patients with high heterogeneity of the oestrogen receptor within the same tumour as compared to patients with low heterogeneity, shows study from Karolinska Institutet in Sweden. The study, which is published in the Journal of the National Cancer Institute, shows that the higher risk of death over a span of 25 years is independent of other known tumour markers and also holds true for Luminal A breast cancer, a subtype with a generally good prognosis.

The most common form of breast cancer is oestrogen-receptor-positive, so called hormone-sensitive breast cancer. This means that the tumour needs the female hormone oestrogen to grow. Women who develop this kind of breast cancer have a remaining long-term risk of dying of the disease. It is also known that the oestrogen receptor can change when a breast cancer tumour spreads, which affects survival. Why this is the case, however, is not known, but a possible explanation is that there are tumour cells in one and the same tumour with varying degrees of expression of the oestrogen receptor. This is known as intra-tumour heterogeneity.

Advertisement


In the present study, Swedish and American researchers sought to discover if breast cancer patients with high heterogeneity of the oestrogen receptor in their breast cancer tumour have a higher long-term risk of dying. To this end, they studied the fates of 593 patients in a clinical study, who had been either treated with tamoxifen or not treated with systemic therapy after surgery. All women had been diagnosed with post-menopausal oestrogen-receptor-positive breast cancer between 1976 and 1990.

"Our study shows that patients with high intra-tumour heterogeneity of the oestrogen receptor were twice as likely to die up to 25-years after their diagnoses as compared to patients with low heterogeneity," says Linda Lindström, researcher at the Department of Biosciences and Nutrition, Karolinska Institutet. "And this was independent of whether or not they'd received tamoxifen and of other known tumour markers."
Advertisement

The researchers also discovered that the greater risk of death for patients with high intra-tumour heterogeneity also applied to patients with Luminal A breast cancer, a subtype of oestrogen-receptor-positive breast cancer that is considered to have a good prognosis.

"Patients with Luminal A breast cancer and high intra-tumour heterogeneity of the oestrogen receptor were also twice as likely to die from the disease," continues Dr Lindström. "This is interesting given that patients with Luminal A breast cancer subtype are generally thought to have a good prognosis. We believe that if validated, these new findings should be useable within the near future."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Breast Cancer Facts Cancer Facts Death Facts Cancer Tattoos A Body Art 

Recommended Reading
Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for ......
Consumption of Red Meat Increases Breast Cancer Risk
Red meat consumption has long been suspected of contributing to cancer development. Find out how ......
Inflammatory Breast Cancer
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and ......
Male Breast Cancer
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of ......
Breast Biopsy
Breast biopsy involves removing a sample of breast tissue to determine whether it is cancerous or .....
Mastitis
Mastitis is a common cause of tenderness, swelling and pain in breast, owing to inflammation in the ...
Pagets disease of the breast
A detailed description of the Paget's disease of the breast, characteristic signs and symptoms, dete...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of l...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use